SVRA (Savara Inc.) Stock Analysis - Hedge Fund Holdings
Savara Inc. (SVRA) is a publicly traded Healthcare sector company. As of May 21, 2026, SVRA trades at $4.95 with a market cap of $1.01B and a P/E ratio of -9.48. SVRA moved +7.84% today. Year to date, SVRA is -12.41%; over the trailing twelve months it is +62.04%. Its 52-week range spans $1.89 to $7.01. Analyst consensus is strong buy with an average price target of $11.00. Rallies surfaces SVRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns SVRA stock?
Hedge funds tracked by Rallies that own SVRA include Farallon Capital and Orbimed Advisors. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Savara Inc..
SVRA Key Metrics
Key financial metrics for SVRA
Metric
Value
Price
$4.95
Market Cap
$1.01B
P/E Ratio
-9.48
EPS
$-0.53
Dividend Yield
0.00%
52-Week High
$7.01
52-Week Low
$1.89
Volume
476
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-118.84M
Gross Margin
0.00%
Top Hedge Funds Holding SVRA
Farallon Capital holds 5.00M shares of SVRA, changed +0.00% as of Sep 30, 2025.
Orbimed Advisors holds 635.00K shares of SVRA, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own SVRA include Farallon Capital and Orbimed Advisors. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Savara Inc..
Does Rallies show 13F holders for SVRA?
Yes. Rallies tracks hedge fund and 13F ownership data for SVRA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SVRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SVRA. It does not provide personalized investment advice.